http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5260474-B2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-433 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 |
| filingDate | 2009-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-5260474-B2 |
| titleOfInvention | RAF kinase inhibitor |
| abstract | <P>PROBLEM TO BE SOLVED: To provide a compound having raf kinase inhibiting activity and a treatment of cancerous cell growth mediated by the compound. <P>SOLUTION: The compounds are ureido-thiophene-carboxylic acid methyl esters represented by the formula, such as 5-bromomethyl-3-(3-p-tolylureido)-thiophene-2-carboxylic acid methyl ester, 5-tert-butyl-3-[3-(5-trifluoromethyl-[1, 3, 4]-thiadiazol-2-yl)ureido]-thiophene-2-carboxylic acid methyl ester, or the like. <P>COPYRIGHT: (C)2010,JPO&INPIT |
| priorityDate | 1997-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 219.